Get the Stockscreener App
11.77
2.73%
-0.33
Meiragtx Holdings Plc stock is traded at $11.77, with a volume of 497.31K.
It is down -2.73% in the last 24 hours and up +1.47% over the past month.
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
See More
Previous Close:
$12.10
Open:
$12.13
24h Volume:
497.31K
Relative Volume:
0.56
Market Cap:
$1.09B
Revenue:
$79.76M
Net Income/Loss:
$-120.53M
P/E Ratio:
-7.9046
EPS:
-1.489
Net Cash Flow:
$3.75M
1W Performance:
-5.39%
1M Performance:
+1.47%
6M Performance:
+45.31%
1Y Performance:
+41.64%
1-Day Range:
$11.69
$12.33
1-Week Range:
$11.69
$12.87
52-Week Range:
$6.62
$15.35
Meiragtx Holdings Plc Stock (MGTX) Company Profile
Name
Meiragtx Holdings Plc
Sector
Industry
Phone
646-860-7985
Address
655 THIRD AVENUE, NEW YORK, NY
Compare MGTX vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGTX
Meiragtx Holdings Plc
|
11.77 | 1.09B | 79.76M | -120.53M | 3.75M | -1.489 |
VRTX
Vertex Pharmaceuticals Inc
|
477.36 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
656.01 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
918.22 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.23 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
271.77 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-24-25 | Initiated | H.C. Wainwright | Buy |
| Oct-21-25 | Initiated | Raymond James | Strong Buy |
| Jul-31-24 | Resumed | Chardan Capital Markets | Buy |
| Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
| Sep-15-20 | Resumed | BofA Securities | Buy |
| Sep-03-19 | Initiated | Piper Jaffray | Overweight |
| Feb-27-19 | Reiterated | Chardan Capital Markets | Buy |
| Jul-03-18 | Initiated | Barclays | Overweight |
| Jul-03-18 | Initiated | BofA/Merrill | Buy |
View All
Meiragtx Holdings Plc Stock (MGTX) Latest News
MGTX|MeiraGTx Holdings PLC|Price:11.770|Chg%:-0.330 - TradingKey
Form 144 MEIRAGTX HOLDINGS PLC For: 21 July By Investing.com - Investing.com Australia
Form 4 MeiraGTx Holdings PLC For: 21 July By Investing.com - Investing.com Nigeria
MeiraGTx CFO & COO Giroux sells $700,560 in shares By Investing.com - Investing.com Nigeria
MeiraGTx CFO & COO Giroux sells $700,560 in shares - Investing.com India
Form 144 MEIRAGTX HOLDINGS PLC For: 21 July - Investing.com India
MeiraGTx CFO, COO Richard Giroux disposes of 56,000 shares for $700,560 - Bitget
MGTX (MGTX) affiliate files to sell 56,000 ordinary shares via Form 144 - Stock Titan
A Quick Look at Today's Ratings for MeiraGTx Holdings(MGTX.US), With a Forecast Between $19 to $30 - Moomoo
Penny Renee Fleck Net Worth (2026) - GuruFocus
MeiraGTx (MGTX) moves 5.5% higher: Will this strength last? - MSN
Wall Street Analysts See a 128.14% Upside in MeiraGTx (MGTX): Can the Stock Really Move This High? - Yahoo Finance
(MGTX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
What This MeiraGTx Insider Sale Might Mean With Two Drug Filings Near - The Motley Fool
What This MeiraGTx Insider Sale Might Mean With Two Drug Filings Near - The Motley Fool
MeiraGTx wins $400M investment from Oberland Capital - MSN
Cantor Fitzgerald Initiates MeiraGTx Holdings(MGTX.US) With Buy Rating, Announces Target Price $20 - Moomoo
Latham & Watkins Advises MeiraGTx on US$400 Million Strategic Investment by Oberland Capital - Latham & Watkins LLP
MeiraGTx (MGTX) Moves 5.5% Higher: Will This Strength Last? - Yahoo Finance
RBC Capital Adjusts MeiraGTx Price Target to $26 From $25, Maintains Outperform Speculative Risk Rating - Moomoo
H.C. Wainwright reiterates MeiraGTx stock rating on financing deal - Investing.com
MeiraGTx Secures Major Royalty Financing and Restructures Debt - The Globe and Mail
H.C. Wainwright reiterates MeiraGTx stock rating on financing deal By Investing.com - Investing.com South Africa
MeiraGTx Holdings (MGTX) Is Up 8.5% After Securing US$425M In New Funding Pathways – Has The Bull Case Changed? - simplywall.st
Meiragtx chief scientific officer Naylor sells $409,470 in shares By Investing.com - Investing.com UK
Form 4 MeiraGTx Holdings PLC For: 7 July By Investing.com - Investing.com India
Insider Sell: Stuart Naylor Sells 27,659 Shares of MeiraGTx Holdings PLC (MGTX) - GuruFocus
Meiragtx chief scientific officer Naylor sells $409,470 in shares - Investing.com
MeiraGTx (MGTX) chief scientist sells 27,659 shares in pre-set 10b5-1 trades - Stock Titan
Exclusive BAC Article: MeiraGTx; AAV2-hAQP1 Q2 207 Data Xerostomia, BLA Filing 1st Half 2027, Bota-Vec Acquisition, Oberland Capital Cash Infusion, And Catalysts (NASDAQ:MGTX) - Seeking Alpha
Form 144 MeiraGTx Holdings plc For: 7 July By Investing.com - Investing.com Nigeria
MeiraGTx secures up to $400M from Oberland Capital By Investing.com - Investing.com South Africa
Meiragtx Holdings Plc shares rose 3.5% in pre-market trading. - Bitget
MGTX (NASDAQ): Proposed resale notice for 27,659 ordinary shares - Stock Titan
MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec - Investing News Network
MeiraGTx Secures $400 Million Investment from Oberland Capital to Accelerate Gene Therapy Commercialization - Minichart
Oberland pours up to $400M into MeiraGTx eye gene therapies - Yahoo Finance
MeiraGTx secures up to $400M from Oberland Capital - Investing.com
MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec) - The Manila Times
MeiraGTx Secures Up To $375 Million Royalty Financing, Adds $10 Million Equity, Retires Perceptive Debt - TradingView
MeiraGTx (Nasdaq: MGTX) lands $400M Oberland royalty and equity deal - Stock Titan
MeiraGTx Announces $400 Million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (Bota-vec) - Moomoo
Meiragtx Holdings Plc Stock (MGTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.46%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):